| Literature DB >> 31736811 |
Philippe Vignaud1,2, Karen T Reilly3, Clément Donde1,2, Frédéric Haesebaert1,2, Jérôme Brunelin1,2.
Abstract
Objectives: Recent clinical studies and meta-analyses have reported the clinical effects of mindfulness-based interventions as a complementary treatment for patients with schizophrenia, but their possible efficacy in patients with first episode of psychosis (FEP) and in individuals with ultra-high risk (UHR) of transition to psychosis is less clear. Here, we investigated the current evidence on the usefulness of mindfulness-based interventions in these two populations.Entities:
Keywords: MBCT; MBSR; first psychotic episode; mindfulness; ultra-high risk for transition to psychosis
Year: 2019 PMID: 31736811 PMCID: PMC6837071 DOI: 10.3389/fpsyt.2019.00797
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
Main results from included studies investigating group-based mindfulness-based interventions in first psychotic episode and at risk for psychosis populations.
| Authors | No. Patients/type | Design | Average Age(SD) | Sex | N control group | Group-based Mindfulness Intervention | Timing of evaluations | Main results |
|---|---|---|---|---|---|---|---|---|
|
| 19 | open | ND | ND | NA | 8 sessions, 1h, 1 session/week | post | - high participation and acceptability-Significant decrease in CORE-OM distress score (from 300 to 90; p < 0,01) |
|
| 19/FEP | open | 31.8(5.2) | 14 M/5 F | NA | 8 sessions, 1 h, 2 sessions/week for 4 weeks-formal practice | ND | -No increase in PANSS positive symptoms scores–Significant reduction in agoraphobia and psychoneurotic scores (SCL)-Tendency towards an improvement in non-aversion trait on the SMQ (p = 0.079) |
|
| 10/FEP | open | 29 | 7 M/3 F | NA | 8 sessions, 1.5 h,1 session/week | ND | -Improvement in quality of life, sadness and anxiety scores (CORE-OM)-improvement on the SMQ-Non-significant clinical effect on all 3 scales |
|
| 12/FEP | open | 29,1(8,1) | 8M/4 F | NA | 8 sessions, between 60 and 75 min1 session/week | post&+3 months | -Significant improvement notably control of negative emotions (CERQ)-Significant reduction of depression and anxiety symptoms (BPRS). |
|
| 14/< 5 years | open | 47.0(12.2) | 4 M/10 F | NA | 7 sessions, 1.5h, 1 session/week | post | -Significant improvement in depression scores (DASS 21 and BDI II)-Improvement in general psychopathology (PANSS G2)-Significant improvement in quality of life (SF12) |
|
| 138/< 5 years | RCT | 23.8(6.8) | 24 M/22 F | 1 psycho-education group (n = 44)1 TAU group (n = 43) | 12 sessions, 3 h, fortnightly, | +1 week&+6 weeks | -Significant improvement in global functioning, insight, and adhesion to Mindfulness program (SLOF)-Reduction of both positive and negative symptoms (PANSS) |
|
| 17/FEP and < 3 years n | RCT | 23.7 | 13 M/4 F | 1 TAU group (n = 10) | 12 sessions, 1 h, 1 session/week | post | - high level of satisfaction (CSQ score = 30.2 (1.6))- significant improvement in depression and asthenia sub-scores of the POMS |
|
| 33/FEP and < 2 years | CT | 19.5(3.8) | 18 M/15 F | 1 TAU group(n = 16) | 6 sessions, 4 h,1session/week | +6 weeks&+12 weeks | –highly feasible- Reduction of positive symptoms at +12 weeks (QSAPS) |
|
| 14/UHR | open | 20.3(3.4) | 3 M/11 F | NA | - web-based application | +2 months | -72% of participants connected at least 7 times and all participants participated in forum discussions- improvement in personal skills (d = 0.70; p = 0.03) and mindfulness skills (d = 0.66; p = 0.04) |
SCL, the Symptoms C`heck-List 90; PANSS, Positive and Negative Symptoms Scale; SMQ, Southampton Mindfulness Questionnaire; BPRS, Brief Psychiatric Rating Scale; CORE-OM, Clinical Outcome in Routine Evaluation – Outcome Measure; DASS 21, Depression and Anxiety Symptoms Scale; BDI-II, Beck Depression Inventory; SLOF, Specific Level Of Functioning Scale; CSQ, Client Satisfaction Questionnaire; POMS, Profile of Mood States; -QSAPS, Quick Scale for the Assessment of Positive Symptoms; SF-12, Short Form 12 items. MADRS, Montgomery Asberg Depression Rating Scale. SD: Standard deviation; NA, Not applicable; ND, Not Done; TAU, Treatment as usual.